Similar Articles
951 Adjuvant sorafenib in hepatocellular carcinoma: A cautionary comment of STORM trial
952 Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinoma
953 Reversal of multidrug resistance of hepatocellular carcinoma cells by metformin through inhibiting NF-κB gene transcription
954 Metastatic recurrence to a solitary lymph node four years after hepatic lobectomy for primary hepatocellular carcinoma
955 Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms
956 Cancer-associated fibroblasts in hepatocellular carcinoma
957 Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis
958 Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects
959 Progress in systemic therapy of advanced hepatocellular carcinoma
960 Specific CD8+ T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA